OPKO Health (OPK)
(Delayed Data from NSDQ)
$1.62 USD
+0.01 (0.62%)
Updated Feb 6, 2025 04:00 PM ET
After-Market: $1.62 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for OPKO Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -188.86 | -328.41 | -30.14 | 30.59 |
Depreciation/Amortization & Depletion | NA | 106.52 | 109.82 | 79.50 | 86.21 |
Net Change from Assets/Liabilities | NA | 21.80 | 42.65 | -20.48 | -97.61 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 32.35 | 80.75 | 9.46 | 20.29 |
Net Cash From Operating Activities | NA | -28.20 | -95.19 | 38.34 | 39.48 |
Property & Equipment | NA | -13.56 | -22.63 | 33.87 | -33.44 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | -1.76 | -4.00 | 0.00 |
Investments | NA | -4.64 | 115.42 | 6.08 | 15.11 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -18.20 | 91.04 | 35.95 | -18.33 |
Uses of Funds
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -0.27 | -0.77 | 1.08 | 0.76 |
Issuance (Repayment) of Debt | NA | -3.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | -8.03 | 23.75 | -11.24 | -35.83 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | -0.19 | 0.00 |
Net Cash from Financing Activities | NA | -11.30 | 22.97 | -10.35 | -35.08 |
Effect of Exchange Rate Changes | NA | 0.39 | -0.34 | -1.44 | 0.69 |
Net Change In Cash & Equivalents | NA | -57.31 | 18.48 | 62.50 | -13.24 |
Cash at Beginning of Period | NA | 153.19 | 134.71 | 72.21 | 85.45 |
Cash at End of Period | NA | 95.88 | 153.19 | 134.71 | 72.21 |
Diluted Net EPS | NA | -0.25 | -0.46 | -0.05 | 0.05 |
Fiscal Year End for OPKO Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -67.25 | -92.14 | -81.84 | -188.86 |
Depreciation/Amortization & Depletion | NA | 75.47 | 50.92 | 26.34 | 106.52 |
Net Change from Assets/Liabilities | NA | 49.15 | 28.92 | 14.21 | 21.80 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | -196.45 | -49.70 | 5.72 | 32.35 |
Net Cash From Operating Activities | NA | -139.08 | -62.00 | -35.57 | -28.20 |
Property & Equipment | NA | -19.43 | -11.56 | -4.40 | -13.56 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 45.28 | 0.00 | 0.00 | -4.64 |
Other Investing Activities | NA | 210.38 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 236.23 | -11.56 | -4.40 | -18.20 |
Uses of Funds
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -73.97 | -50.21 | -50.00 | -0.27 |
Issuance (Repayment) of Debt | NA | 328.83 | 83.71 | 83.71 | -3.00 |
Increase (Decrease) Short-Term Debt | NA | -16.84 | -6.45 | -4.54 | -8.03 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -13.39 | -8.56 | -8.56 | 0.00 |
Net Cash from Financing Activities | NA | 224.64 | 18.50 | 20.61 | -11.30 |
Effect of Exchange Rate Changes | NA | 2.40 | -0.25 | -0.89 | 0.39 |
Net Change In Cash & Equivalents | NA | 324.18 | -55.31 | -20.24 | -57.31 |
Cash at Beginning of Period | NA | 95.88 | 95.88 | 95.88 | 153.19 |
Cash at End of Period | NA | 420.07 | 40.58 | 75.64 | 95.88 |
Diluted Net EPS | NA | 0.03 | -0.01 | -0.12 | -0.09 |